Deere & Co: Form 10-Q for the period ended Jul 30, 2023
Filed with the SEC on Aug 31, 2023 and accepted by EDGAR at Aug 31, 2023, 14:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-05-01 to 2023-07-30 | $15.80bn | us-gaap:Revenues |
| Revenue | 9 months2022-10-31 to 2023-07-30 | $45.84bn | us-gaap:Revenues |
| Research and development | 3 months2023-05-01 to 2023-07-30 | $528.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-10-31 to 2023-07-30 | $1.57bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-05-01 to 2023-07-30 | $1.11bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-10-31 to 2023-07-30 | $3.39bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-05-01 to 2023-07-30 | $3.52bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-10-31 to 2023-07-30 | $9.93bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-05-01 to 2023-07-30 | $623.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-10-31 to 2023-07-30 | $1.67bn | us-gaap:InterestExpense |
| Income tax | 3 months2023-05-01 to 2023-07-30 | $636.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-10-31 to 2023-07-30 | $2.16bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-05-01 to 2023-07-30 | $2.98bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-10-31 to 2023-07-30 | $7.80bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-05-01 to 2023-07-30 | $10.20 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-10-31 to 2023-07-30 | $26.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-05-01 to 2023-07-30 | $10.24 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-10-31 to 2023-07-30 | $26.48 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-05-01 to 2023-07-30 | 292,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-10-31 to 2023-07-30 | 295,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-10-31 to 2023-07-30 | $2.90bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-10-31 to 2023-07-30 | $887.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-10-31 to 2023-07-30 | $1.06bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2022-10-31 to 2023-07-30 | $4.66bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-07-30 | $6.58bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2023-07-30 | $103.40bn | us-gaap:Assets |
| Total liabilities | At period end2023-07-30 | $80.25bn | us-gaap:Liabilities |
| Current portion of debt | At period end2023-07-30 | $17.14bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2023-07-30 | $23.05bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-07-30 | 288,000,577 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001558370-23-015380. Last ingested by Listed: Nov 2, 2026, 11:18 ET. Listed shows no prices and gives no investment advice.